A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS

被引:6
作者
Buti, M. [1 ]
Gane, E. [2 ]
Seto, W. K. [3 ]
Chan, H. L. Y. [4 ]
Chuang, W. -L. [5 ]
Stepanova, T. [6 ]
Hui, A. J. [7 ]
Lim, Y. -S. [8 ]
Mehta, R. [9 ]
Janssen, H. L. A. [10 ,11 ]
Acharya, S. K. [12 ]
Flaherty, J. F. [13 ]
Massetto, B. [13 ]
Cathcart, A. [13 ]
Dinh, P. [13 ]
Subramanian, G. M. [13 ]
McHutchison, J. G. [13 ]
Pan, C. [14 ]
Brunetto, M. [15 ]
Izumi, N. [16 ]
Marcellin, P. [17 ]
机构
[1] Hosp Gen Univ Vall dHebron, Barcelona, Spain
[2] Auckland Clin Studies, Auckland, New Zealand
[3] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[5] Kaoshing Med Univ Hosp, Kaoshing, Taiwan
[6] Modern Med Clin, Moscow, Russia
[7] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China
[8] Asan Med Ctr, Seoul, South Korea
[9] Nirmal Hosp Private Ltd, Surat, India
[10] Toronto Western Hosp, Toronto, ON, Canada
[11] Erasmus MC, Rotterdam, Netherlands
[12] All India Inst Med Sci, New Delhi, India
[13] Gilead Sci, Foster City, CA USA
[14] New Discovery LLC, Flushing, NY USA
[15] Univ Hosp Pisa, Pisa, Italy
[16] Musashino Red Cross Hosp, Tokyo, Japan
[17] Hop Beaujon, Clichy, France
关键词
D O I
10.1016/S0168-8278(16)01637-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
GS06
引用
收藏
页码:S135 / S136
页数:2
相关论文
共 50 条
[21]   TENOFOVIR ALAFENAMIDE (TAF) COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH CHRONIC HBV: WEEK 96 EFFICACY AND SAFETY RESULTS IN CHINESE PATIENTS ENROLLED IN 2 GLOBAL PHASE 3 STUDIES [J].
Chan, Henry Lik-Yuen ;
Seto, Wai Kay ;
Fung, Scott ;
Hou, Jinlin ;
Pan, Calvin ;
Chuang, Wan-Long ;
Chang, Ting-Tsung ;
Hui, Aric-Josun ;
Chen, Chi-Yi ;
Tsang, Tak Yin Owen ;
Yang, Jenny ;
Flaherty, John ;
Gaggar, Anuj ;
Mo, Shuyuan ;
Kao, Jia-Horng .
GUT, 2018, 67 :A302-A302
[22]   A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS [J].
Chan, Henry Lik Yuen ;
Lampertico, Pietro ;
Buti, Maria ;
Fung, Scott ;
Ahn, Sang Hoon ;
Chuang, Wan-Long ;
Tak, Won Young ;
Ramji, Alnoor ;
Chen, Chi-Yi ;
Tam, Edward ;
Bae, Ho ;
Ma, Xiaoli ;
Flaherty, John ;
Gaggar, Anuj ;
Lau, Audrey ;
Feierbach, Becket ;
Wu, George ;
Suri, Vithika ;
Subramanian, Mani ;
Huy Trinh ;
Yoon, Seung-Kew ;
Agarwal, Kosh ;
Lim, Young-Suk .
GUT, 2019, 68 :A142-A143
[23]   Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial [J].
Buti, Maria ;
Gane, Edward ;
Seto, Wai Kay ;
Chan, Henry L. Y. ;
Chuang, Wan-Long ;
Stepanova, Tatjana ;
Hui, Aric-Josun ;
Lim, Young-Suk ;
Mehta, Rajiv ;
Janssen, Harry L. A. ;
Acharya, Subrat K. ;
Flaherty, John F. ;
Massetto, Benedetta ;
Cathcart, Andrea L. ;
Kim, Kyungpil ;
Gaggar, Anuj ;
Subramanian, G. Mani ;
McHutchison, John G. ;
Pan, Calvin Q. ;
Brunetto, Maurizia ;
Izumi, Namiki ;
Marcellin, Patrick .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03) :196-206
[24]   Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide [J].
Hong, Hyeyeon ;
Choi, Won-Mook ;
Lee, Danbi ;
Shim, Ju Hyun ;
Kim, Kang Mo ;
Lim, Young-Suk ;
Lee, Han Chu ;
Choi, Jonggi .
CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) :49-63
[25]   THREE YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B, PRELIMINARY ANALYSIS [J].
Lee, Samuel S. ;
Heathcote, E. Jenny ;
Sievert, William ;
Trinh, Huy N. ;
Kaita, Kelly D. ;
Younossi, Zobair M. ;
George, Jacob ;
Shiffman, Mitchell L. ;
Marcellin, Patrick ;
Sorbel, Jeff ;
Anderson, Jane ;
Mondou, Elsa ;
Ouinn, Joe ;
Rousseau, Franck .
HEPATOLOGY, 2009, 50 (04) :538A-538A
[26]   Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB) [J].
Pan, Calvin Q. ;
Brunetto, Maurizia R. ;
Hui, Aric Josun ;
Mehta, Rajiv ;
Flaherty, John F. ;
Suri, Vithika ;
Wu, George ;
Gaggar, Anuj ;
Subramanian, Mani ;
Nishiguchi, Shuhei ;
Kim, Hyung J. ;
Gane, Edward J. ;
Chuang, Wan-Long .
HEPATOLOGY, 2017, 66 :482A-482A
[27]   IMPROVED BONE AND RENAL SAFETY AT 1 YEAR AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF): RESULTS FROM 2 PHASE 3 STUDIES IN HBEAG-POSITIVE AND HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) [J].
Chan, Henry Lek-Yuen ;
Pan, Calvin ;
Brunetto, Maurizia ;
Hui, Aric Josun ;
Mehta, Rajiv ;
Flaherty, John F. ;
Suri, Vithika ;
Wu, George ;
Gaggar, Anuj ;
Subramanian, G. Mani ;
Nishiguchi, Shuhei ;
Kim, Hyung Joon ;
Gane, Edward ;
Chuang, Wan Long .
GUT, 2018, 67 :A97-A98
[28]   Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics [J].
Hsu, Yao-Chun ;
Wei, Mike T. ;
Nguyen, Mindie H. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (11) :999-1008
[29]   Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients [J].
Hye Yeon Chon ;
Sang Hoon Ahn ;
Yoon Jun Kim ;
Jung-Hwan Yoon ;
Jeong-Hoon Lee ;
Dong Hyun Sinn ;
Seung Up Kim .
Hepatology International, 2021, 15 :1328-1336
[30]   Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients [J].
Chon, Hye Yeon ;
Ahn, Sang Hoon ;
Kim, Yoon Jun ;
Yoon, Jung-Hwan ;
Lee, Jeong-Hoon ;
Sinn, Dong Hyun ;
Kim, Seung Up .
HEPATOLOGY INTERNATIONAL, 2021, 15 (06) :1328-1336